Press release
Erythropoietin Drugs Market Update 2023: Revenue to Cross USD 14.41 Billion 2028 | CAGR of 5.7%
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/59
Drivers of growth: The growth of the market is driven by factors such as the increasing prevalence of chronic kidney diseases, the rise in the number of cancer patients undergoing chemotherapy, and the growing geriatric population.
Types of erythropoietin drugs: The two major types of erythropoietin drugs are biosimilars and biologics. Biosimilars are expected to dominate the market due to their cost-effectiveness compared to biologics.
Application areas: Erythropoietin drugs are primarily used in the treatment of anemia caused by chronic kidney disease, cancer, and other diseases. They are also used to reduce the need for blood transfusions during surgeries.
Regional analysis: North America held the largest share of the market in 2020, followed by Europe and Asia Pacific. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period.
Market Segmentation:
On the basis product type, epoetin-alfa segment is anticipated to grow with the highest revenue throughout the forecast period, owing to increase in sales of Epogen, which is the top selling brand of erythropoietin, developed by Amgen. Epogen indicated notable growth in the U.S. market as Amgen procured patent protection for this product.
By application, the kidney disorders (ESRD and Dialysis) segment accounted for a major share in 2020, and is expected to exhibit a prominent growth rate during the forecast period, owing to increase in cases of patients with kidney disease. Furthermore, ESRD is majorly responsible for prescription of EPO treatment among renal disease patients.
Request for Customization -
https://www.alliedmarketresearch.com/request-for-customization/59
Competitive Landscape:
AMGEN INC.
JOHNSON AND JOHNSON
ROCHE DIAGNOSTICS
HOSPIRA INC.
LG LIFE SCIENCES LTD.
BIOCON
INTAS PHARMACEUTICALS
TEVA PHARMACEUTICAL INDUSTRIES LTD.
RANBAXY LABORATORIES LTD.
CELLTRION, INC
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/59
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Browse more latest healthcare reports:
Topical Oxygen Therapy Market https://www.alliedmarketresearch.com/topical-oxygen-therapy-market-A16966
Hemostats Market https://www.alliedmarketresearch.com/hemostats-market-A16840
Companion Animal Diagnostics Market https://www.alliedmarketresearch.com/companion-animal-diagnostics-market-A11127
Radiosurgery Systems Market https://www.alliedmarketresearch.com/radiosurgery-systems-market-A14841
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erythropoietin Drugs Market Update 2023: Revenue to Cross USD 14.41 Billion 2028 | CAGR of 5.7% here
News-ID: 3077595 • Views: 195
More Releases from Allied Market Research
Astrology Market : Booming With an Impressive CAGR of 5.7% From 2021 To 2031 | A …
According to a new report published by Allied Market Research, titled, "Astrology Market," The Astrology Market Size was valued at $12.8 billion in 2021, and is estimated to reach $22.8 billion by 2031, growing at a CAGR of 5.7% from 2022 to 2031.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/32229
Since the beginning of time, humans have looked to the stars for guidance. Astrology has been practiced for thousands of…
Hybrid Devices Market Expected to Reach $151.88 Billion by 2030-Allied Market Re …
The global hybrid devices market is influenced by a number of factors such as bigger screens and faster speed than tablets, increasing acceptance of hybrid devices for enterprise mobility, and use of wireless display (widi) technology. However, higher price compared with other computing devices and heavy weight restrain the market growth.
☛ Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/1506
KEY FINDINGS OF THE STUDY:
► On the basis of type, in…
Smart Meter Data Management Market Expected to Reach $5.2 Billion by 2030-Allied …
Smart meter data management software helps companies and organizations to examine large set of data for uncovering useful information to increase their decision-making capability. In addition, it provides a centralized data collection center to companies, improves the data validation process, and delivers real-time updates about various critical issues in the data collected from smart meters. Furthermore, smart meter data management system gathers data from analog and smart meter, aggregates and…
Cloud-Based Business Analytics Software Market Expected to Reach $57,055 Million …
According to a recent report published by Allied Market Research, titled, Cloud-Based Business Analytics Software Market by Deployment Model, End User, and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global Cloud-Based Business Analytics Software Market was valued at $28,854 million in 2016, and is projected to reach at $57,055 million by 2023, growing at a CAGR of 10.2% from 2017 to 2023. In 2016, the hybrid cloud segment…
More Releases for Erythropoietin
Erythropoietin Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Erythropoietin market.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Click to view the…
Global Erythropoietin Drugs Market: Segmentation
The global erythropoietin drugs market has been projected in a report by Transparency Market Research (TMR) to witness a rising focus on product development adopted by prominent companies operating in the industry. Players could be persuaded to search for new distributors due to the escalating level of competition in the market. For the purpose of earning an improved return of investment (ROI), players have been predicted to set their focus…
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms of…
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports.
Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to…
European Erythropoietin Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title European Erythropoietin Market Outlook 2022 to its growing collection of premium market research reports.
Erythropoietin drugs are protein therapeutics, which is used to treat various types of anaemia. These drugs play a significant role in treating CKD related anaemia and cancer related anaemia. Since its inception, the erythropoietin drugs market has witnessed various technological advancements, which have resulted in development of…
Global Erythropoietin Market Research Report 2017
This report studies Erythropoietin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Erythropoietin in these regions, from 2011 to…
